Clincosm LogoSign in Get a demo

melanoma stage iv

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Liquid Biopsy, Melanoma (Skin), Melanoma Stage III Trial in Rome (Affinity Mediated Transport Amplification (AMT))

Recruiting
  • Liquid Biopsy
  • +4 more
  • Affinity Mediated Transport Amplification (AMT)
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jul 13, 2023

Melanoma, Melanoma (Skin), Melanoma Stage III Trial in Belarus, India, Russian Federation (BCD-217, BCD-100, Placebo)

Recruiting
  • Melanoma
  • +6 more
  • BCD-217
  • +2 more
  • Babruysk, Belarus
  • +62 more
Feb 8, 2023

Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

Recruiting
  • Leptomeningeal Metastasis
  • +2 more
  • intrathecal nivolumab and intrathecal ipilimumab
  • Geneva, Switzerland
  • +2 more
Dec 18, 2022

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Melanoma Stage IV, Melanoma Stage III, Immunetherapy Trial (nivolumab)

Not yet recruiting
  • Melanoma Stage IV
  • +3 more
  • (no location specified)
Dec 14, 2022

Melanoma Stage III, Melanoma Stage IV Trial in San Francisco (Binimetinib, Imatinib)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • San Francisco, California
    University of California, San Francisco
Dec 6, 2022

Malignant Melanoma, Melanoma (Skin), Melanoma Stage III Trial in United Kingdom (SCIB1 DNA vaccine)

Recruiting
  • Malignant Melanoma
  • +3 more
  • SCIB1 DNA vaccine
  • Cardiff, United Kingdom
  • +6 more
Dec 7, 2022

Melanoma Stage III, Melanoma Stage IV, Inoperable Disease Trial in Tampa (Interleukin-2, Ipilimumab, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Dec 6, 2022

Melanoma Stage IV, Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma Trial in Oslo (Fecal Microbiota

Recruiting
  • Melanoma Stage IV
  • +4 more
  • Fecal Microbiota Transplant (FMT)
  • Oslo, Norway
    Oslo University Hospital
Aug 29, 2022

Melanoma Stage III, Melanoma Stage IV, Unresectable Melanoma Trial in Worldwide (BNT111, Cemiplimab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • BNT111
  • Cemiplimab
  • Tucson, Arizona
  • +53 more
Aug 24, 2022

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Melanoma Stage Iii, Melanoma Stage Iv, Melanoma Trial in Chapel Hill (Denosumab, Pembrolizumab, Nivolumab)

Active, not recruiting
  • Melanoma Stage Iii
  • +4 more
  • Chapel Hill, North Carolina
    UNC Lineberger Comprehensive Cancer Center
Jul 20, 2022

NSCLC Stage IV, Melanoma Stage IV, Unresectable Melanoma Trial in Montréal (Camu Camu Capsules (Camu Camu powder encapsulated

Recruiting
  • NSCLC Stage IV
  • +3 more
  • Camu Camu Capsules (Camu Camu powder encapsulated (500mg each) + ICI
  • Montréal, Quebec, Canada
    Centre hospitalier de l'Université de Montréal (CHUM)
Jul 18, 2022

Glioblastoma, Melanoma Stage IV, Melanoma Recurrent Trial in United Kingdom, United States (ST101)

Recruiting
  • Glioblastoma
  • +11 more
  • San Francisco, California
  • +11 more
Jul 13, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (Fecal microbiota transplantation)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Fecal microbiota transplantation
  • Amsterdam, Netherlands
    Antoni van Leeuwenhoek
Jul 8, 2022

Patients With Stage 0-IV Melanoma in Real Clinical Practice

Recruiting
  • Melanoma
  • +7 more
  • surgery (any volume) and / or pharmaceuticals treatment initiated or planned or only dynamic observation, in accordance with current clinical guidelines
  • Moscow, Russian Federation
    N.N. Blokhin Russian Cancer Research Center
Jun 12, 2022

Toxicity and Symptom Burden in Chronic Cancer Survivors With

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +7 more
  • Assessment
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 6, 2022

metAsTatI? melanOma Treated With dabrafeNib and trAmetinib in

Recruiting
  • Melanoma Stage III
  • +2 more
  • Barnaul, Alatai, Russian Federation
  • +14 more
May 29, 2022

Melanoma Stage III, Melanoma Stage IV, BRAF V600 Mutation Trial in Tampa (Encorafenib Pill, Binimetinib Pill, Nivolumab)

Recruiting
  • Melanoma Stage III
  • +2 more
  • Encorafenib Pill
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
May 27, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Jette (Regorafenib 40 MG Oral Tablet)

Not yet recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Regorafenib 40 MG Oral Tablet
  • Jette, Brussel, Belgium
    UZ Brussels
May 6, 2022

Melanoma Stage III, Melanoma Stage IV Trial in Wollstonecraft, Nedlands (EVX-01, Pembrolizumab 25 MG/ML)

Not yet recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Wollstonecraft, New South Wales, Australia
  • +2 more
May 11, 2022

Melanoma, Melanoma Stage IV, Metastatic Melanoma Trial in Gothenburg (Surgical metastasectomy, Immunotherapy)

Recruiting
  • Melanoma
  • +3 more
  • Gothenburg, Sweden
    Sahlgrenska University Hospital
May 3, 2022

Melanoma Stage Iv, Melanoma Stage Iii, Melanoma Trial in Australia (Denosumab, Nivolumab, Ipilimumab)

Active, not recruiting
  • Melanoma Stage Iv
  • +2 more
  • Albury, New South Wales, Australia
  • +9 more
Apr 6, 2022

Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

Recruiting
  • Sarcoma, Synovial
  • +8 more
  • CYCLOPHOSPHAMIDE and FLUDARABIN
  • +3 more
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 15, 2022